EBS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Emergent BioSolutions Inc

Watchlist Manager

Watchlist

Price: 7.48 USD 0.94%

Market Cap: $386m

	Emergent BioSolutions Inc NYSE:EBS	US
P	PPC Ltd SWB:OZV2	ZA
	Next 15 Group PLC LSE:NFG	UK
	Nordic LEVEL Group AB F:9T2	SE
	Circle Internet Group Inc F:ET9	US

Profitability Summary

Emergent BioSolutions Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

54%

Sustainable 3Y Average Gross Margin

41%

Gross Margin is Increasing

30% > 54%

Low Operating Margin

Negative 3Y Average Operating Margin

-8%

Operating Margin is Increasing

-31% > 9%

Negative Net Margin

-1%

Negative 3Y Average Net Margin

-25%

Net Margin is Increasing

-64% > -1%

Exceptional Free Cash Flow Margin

20%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-49% > 20%

Negative ROE

-2%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-9%

ROIC is Increasing

-20% > -13%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.